On ECHEMI
Home > Drugs > Voglibose Registered Holders
Voglibose structure

Voglibose structure

Voglibose

Voglibose is an N-substituted derivative of valiolamine, excellent inhibitory activity against α-glucosidases and its action against hyperglycemia and various disorders caused by hyperglycemia.Target: α-glucosidasesglibose can inhibit the intestinal α-glucosidases, which are responsible for the digestion of disaccharides such as maltose and sucrose, including maltase and sucrase. The Ki values of Voglibose for sucrase and maltase are about 106and 105 times smaller than the Km values for

Find 11 Related Holders

Benova(Tianjin)Innovation Pharmaceutical Research Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2018-12-24
  • Country:

    China China
  • Address:

    Tianjin Pilot Free Trade Zone (Dongjiang Bonded Port Area) Building 4, Minghai Center, No. 426 Hulunbuir Road, No. 3, 7-901 (multiple addresses exist)
  • Tax NO.:

    91120118MA06HBWM91
  • Registered Funds:

    20 million yuan
  • Website:

  • Email:

  • 1
  • 2
  • Go to Page Go
Recommended Suppliers of Voglibose
View 113 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.